Women who have an increased risk of developing breast cancer due to mutations in cancer susceptibility genes (i.e., BRCA1, BRCA2, PALB2, ATM, and CHEK2) or a familial predisposition undergo adapted screening programs [1] compared to women who are at population risk [2]. This evidence concerns the gene BRCA1 and breast cancer.